-
Why GSK should turn down Unilever’s billionsNews Unilever has offered GSK £50bn for its consumer division. But while the cash will be a temptation, the deal is not in the interests of shareholders or of anyone else, says Matthew Lynn.
News -
Unilever slides and GSK bounces after GSK knocks back £50bn bidNews Unilever shares fell to their lowest level in around five years, after its £50bn takeover bid for GSK’s consumer health unit was rejected.
News -
Why Unilever will have to RemainOpinion Unilever, the consumer-goods giant, is staying in the UK after all. That tells us something important about Brexit, says Matthew Lynn.
Opinion -
Unilever puts the U in U-turnFeatures The Anglo-Dutch consumer-products giant irritated shareholders with plans to redomicile in Rotterdam. Now it has beaten a retreat. Marina Gerner reports.
Features -
Unilever and the erosion of shareholder democracyFeatures The way Unilever went about planning the vote on moving its head office out of the UK wasn’t normal and it wasn’t right, says Merry Somerset Webb.
Features -
Unilever leaves BritainFeatures Consumer-goods giant Unilever has chosen Rotterdam over London for its unified headquarters. Takeover threats and taxes played a part. Alice Gråhns reports.
Features -
A poor deal for deferred pension scheme membersFeatures Some five million deferred members of company pension schemes are missing out on valuable opportunities to make the most of their savings because of poor communications from their former employers.
Features -
Nick Train: the value in Unilever
Features Quality growth companies are still cheap relative to history, thinks fund manager Nick Train.
Features -
Unilever should snub the “crazy cost-cutters”Features Unilever could soon dispose of some of its best-known brands in a bid to appease shareholders. But should it listen to them?
Features
1
2